| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.41e-07 | 6 | 199 | 4 | GO:0140545 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 1.20e-05 | 15 | 199 | 4 | GO:0140776 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.91e-05 | 6 | 199 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 7.84e-05 | 9 | 199 | 3 | GO:0017162 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DENND4A DOCK11 DENND4B EIF2B4 DENND5A ARHGEF28 ARFGEF1 DENND3 ARHGEF10 GNA13 | 1.12e-04 | 231 | 199 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DENND4A DOCK11 RGPD1 NF1 TBC1D1 DENND4B EIF2B4 DENND5A ARHGEF28 ARHGAP23 ARFGEF1 DENND3 RGS16 ARHGEF10 GNA13 | 1.80e-04 | 507 | 199 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DENND4A DOCK11 RGPD1 NF1 TBC1D1 DENND4B EIF2B4 DENND5A ARHGEF28 ARHGAP23 ARFGEF1 DENND3 RGS16 ARHGEF10 GNA13 | 1.80e-04 | 507 | 199 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | transcription factor binding | MKKS MAGEA4 ERCC4 CAND2 PPRC1 JARID2 PER2 NFE2L2 ARNT2 AHR KMT2A CHD6 HSPA1A HSPA1B TADA3 FOXP3 ARNT BRD7 CNOT1 | 2.00e-04 | 753 | 199 | 19 | GO:0008134 |
| GeneOntologyMolecularFunction | unfolded protein binding | 2.73e-04 | 126 | 199 | 7 | GO:0051082 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.95e-04 | 3 | 199 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | 5'-3' RNA exonuclease activity | 5.85e-04 | 4 | 199 | 2 | GO:0004534 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 5.86e-04 | 68 | 199 | 5 | GO:0016279 | |
| GeneOntologyMolecularFunction | type I interferon receptor binding | 5.98e-04 | 17 | 199 | 3 | GO:0005132 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 6.27e-04 | 69 | 199 | 5 | GO:0016278 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 6.61e-04 | 40 | 199 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 7.14e-04 | 71 | 199 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 9.51e-04 | 44 | 199 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 9.69e-04 | 5 | 199 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.26e-03 | 163 | 199 | 7 | GO:0031072 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MKKS KIFBP SPAG1 ARMC3 SLC9C1 ATXN7 STARD9 DIAPH1 WDR35 SEPTIN1 SPAG16 HSPA1A HSPA1B HSPA8 DEUP1 CFAP47 KIF23 SEPTIN4 COPG2 C2CD3 ARHGEF10 CEP70 SENP6 IFT122 SKA3 CCDC102B AGRN | 3.80e-06 | 1058 | 199 | 27 | GO:0007017 |
| GeneOntologyBiologicalProcess | hemopoiesis | ACP6 TRAF6 RIPK1 DOCK11 GON4L MELK BLM JAK1 NF1 PTPRC CLPB NFE2L2 SIGLEC10 AHR KMT2A LOXL3 HSPA1A HSPA1B FOXP3 OSTM1 CASP8 IFNA8 IFNA14 TIPARP IFNA17 TGFBR2 ARNT BRD7 LYL1 | 6.69e-06 | 1223 | 199 | 29 | GO:0030097 |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor-mediated signaling pathway | 7.80e-06 | 14 | 199 | 4 | GO:1903265 | |
| GeneOntologyBiologicalProcess | regulation of Rab protein signal transduction | 1.73e-05 | 6 | 199 | 3 | GO:0032483 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | TRAF6 RIPK1 DOCK11 GON4L BLM JAK1 NF1 PTPRC CLPB AHR KMT2A LOXL3 FOXP3 OSTM1 CASP8 IFNA8 IFNA14 IFNA17 TGFBR2 BRD7 LYL1 | 2.68e-05 | 789 | 199 | 21 | GO:0002521 |
| GeneOntologyBiologicalProcess | telomere maintenance | 3.81e-05 | 168 | 199 | 9 | GO:0000723 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | TRAF6 RIPK1 DOCK11 GON4L BLM JAK1 PTPRC AHR KMT2A LOXL3 FOXP3 CASP8 IFNA8 IFNA14 IFNA17 TGFBR2 BRD7 LYL1 | 5.12e-05 | 640 | 199 | 18 | GO:1903131 |
| GeneOntologyCellularComponent | aryl hydrocarbon receptor complex | 4.66e-05 | 8 | 200 | 3 | GO:0034751 | |
| GeneOntologyCellularComponent | nuclear aryl hydrocarbon receptor complex | 9.11e-05 | 2 | 200 | 2 | GO:0034753 | |
| GeneOntologyCellularComponent | COPI vesicle coat | 2.30e-04 | 13 | 200 | 3 | GO:0030126 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ERCC4 RGPD1 GON4L JARID2 CHTF8 KMT2C PER2 ATXN7 NFE2L2 AHR KMT2A SLBP HSPA1A HSPA1B TADA3 HSPA8 SLX1A RNPC3 ARFGEF1 CASP8 ADNP INTS6 ARNT UPF2 BRD7 BICRAL PTGES3 | 3.06e-04 | 1377 | 200 | 27 | GO:0140513 |
| Domain | PAS | 9.20e-07 | 32 | 197 | 6 | SM00091 | |
| Domain | PAS | 1.34e-06 | 34 | 197 | 6 | PS50112 | |
| Domain | PAS | 1.34e-06 | 34 | 197 | 6 | IPR000014 | |
| Domain | PAS_fold_3 | 3.58e-06 | 23 | 197 | 5 | IPR013655 | |
| Domain | PAS_3 | 3.58e-06 | 23 | 197 | 5 | PF08447 | |
| Domain | PAS | 5.55e-06 | 25 | 197 | 5 | PF00989 | |
| Domain | PAS_fold | 5.55e-06 | 25 | 197 | 5 | IPR013767 | |
| Domain | PAC | 6.82e-06 | 26 | 197 | 5 | IPR001610 | |
| Domain | PAC | 6.82e-06 | 26 | 197 | 5 | SM00086 | |
| Domain | uDENN | 1.50e-05 | 15 | 197 | 4 | PF03456 | |
| Domain | ARM-type_fold | CAND2 ARMC3 DOCK11 FMNL2 NF1 DIAPH1 ZER1 UBR4 ARFGEF1 COPG2 IPO4 ELMO3 UPF2 TTI1 | 1.54e-05 | 339 | 197 | 14 | IPR016024 |
| Domain | DENN | 1.98e-05 | 16 | 197 | 4 | SM00799 | |
| Domain | DENN | 1.98e-05 | 16 | 197 | 4 | PF02141 | |
| Domain | dDENN | 1.98e-05 | 16 | 197 | 4 | PF03455 | |
| Domain | UDENN | 1.98e-05 | 16 | 197 | 4 | PS50946 | |
| Domain | DDENN | 1.98e-05 | 16 | 197 | 4 | PS50947 | |
| Domain | dDENN | 1.98e-05 | 16 | 197 | 4 | SM00801 | |
| Domain | dDENN_dom | 1.98e-05 | 16 | 197 | 4 | IPR005112 | |
| Domain | uDENN_dom | 1.98e-05 | 16 | 197 | 4 | IPR005113 | |
| Domain | DENN | 1.98e-05 | 16 | 197 | 4 | PS50211 | |
| Domain | DENN_dom | 1.98e-05 | 16 | 197 | 4 | IPR001194 | |
| Domain | PAS-assoc_C | 1.08e-04 | 24 | 197 | 4 | IPR000700 | |
| Domain | RSBN1 | 1.11e-04 | 2 | 197 | 2 | IPR026306 | |
| Domain | PAC | 1.50e-04 | 26 | 197 | 4 | PS50113 | |
| Domain | uDENN | 3.86e-04 | 14 | 197 | 3 | SM00800 | |
| Domain | CS | 5.85e-04 | 16 | 197 | 3 | PS51203 | |
| Domain | CS_dom | 5.85e-04 | 16 | 197 | 3 | IPR007052 | |
| Domain | HSP70 | 5.85e-04 | 16 | 197 | 3 | PF00012 | |
| Domain | ARM-like | 6.09e-04 | 270 | 197 | 10 | IPR011989 | |
| Domain | SCA7 | 6.55e-04 | 4 | 197 | 2 | PF08313 | |
| Domain | MABP | 6.55e-04 | 4 | 197 | 2 | PS51498 | |
| Domain | SCA7_dom | 6.55e-04 | 4 | 197 | 2 | IPR013243 | |
| Domain | MABP | 6.55e-04 | 4 | 197 | 2 | IPR023341 | |
| Domain | SCA7 | 6.55e-04 | 4 | 197 | 2 | PS51505 | |
| Domain | HSP70_2 | 7.05e-04 | 17 | 197 | 3 | PS00329 | |
| Domain | Interferon | 7.05e-04 | 17 | 197 | 3 | PF00143 | |
| Domain | INTERFERON_A_B_D | 7.05e-04 | 17 | 197 | 3 | PS00252 | |
| Domain | HSP70_1 | 7.05e-04 | 17 | 197 | 3 | PS00297 | |
| Domain | Interferon_alpha/beta/delta | 7.05e-04 | 17 | 197 | 3 | IPR000471 | |
| Domain | IFabd | 7.05e-04 | 17 | 197 | 3 | SM00076 | |
| Domain | HSP70_3 | 7.05e-04 | 17 | 197 | 3 | PS01036 | |
| Domain | Hsp_70_fam | 8.39e-04 | 18 | 197 | 3 | IPR013126 | |
| Domain | SET | 8.96e-04 | 41 | 197 | 4 | PF00856 | |
| Domain | FYrich_C | 1.08e-03 | 5 | 197 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.08e-03 | 5 | 197 | 2 | IPR003888 | |
| Domain | FYRC | 1.08e-03 | 5 | 197 | 2 | SM00542 | |
| Domain | FYRN | 1.08e-03 | 5 | 197 | 2 | SM00541 | |
| Domain | FYRN | 1.08e-03 | 5 | 197 | 2 | PF05964 | |
| Domain | FYRC | 1.08e-03 | 5 | 197 | 2 | PF05965 | |
| Domain | FYRC | 1.08e-03 | 5 | 197 | 2 | PS51543 | |
| Domain | FYRN | 1.08e-03 | 5 | 197 | 2 | PS51542 | |
| Domain | 4_helix_cytokine-like_core | 1.11e-03 | 74 | 197 | 5 | IPR009079 | |
| Domain | SET | 1.39e-03 | 46 | 197 | 4 | SM00317 | |
| Domain | Haem_d1 | 1.61e-03 | 6 | 197 | 2 | IPR011048 | |
| Domain | Acid_Pase_AS | 1.61e-03 | 6 | 197 | 2 | IPR033379 | |
| Domain | SET_dom | 1.89e-03 | 50 | 197 | 4 | IPR001214 | |
| Domain | SET | 1.89e-03 | 50 | 197 | 4 | PS50280 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 2.24e-03 | 7 | 197 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 2.24e-03 | 7 | 197 | 2 | PS00616 | |
| Pathway | REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING | 1.38e-07 | 6 | 140 | 4 | M27793 | |
| Pathway | REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING | 3.19e-07 | 7 | 140 | 4 | MM15528 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 6.22e-06 | 13 | 140 | 4 | MM14952 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 8.36e-06 | 136 | 140 | 9 | M42547 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.24e-05 | 31 | 140 | 5 | M47964 | |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 2.56e-05 | 18 | 140 | 4 | MM15964 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 3.22e-05 | 19 | 140 | 4 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 4.89e-05 | 21 | 140 | 4 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 5.93e-05 | 22 | 140 | 4 | M47897 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 7.13e-05 | 23 | 140 | 4 | MM14953 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 7.13e-05 | 23 | 140 | 4 | M47452 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 7.26e-05 | 71 | 140 | 6 | M15913 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 7.98e-05 | 45 | 140 | 5 | M39615 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 8.48e-05 | 24 | 140 | 4 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.18e-04 | 26 | 140 | 4 | M982 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.59e-04 | 28 | 140 | 4 | M27254 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.62e-04 | 82 | 140 | 6 | M1002 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 1.94e-04 | 160 | 140 | 8 | MM15990 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 2.09e-04 | 30 | 140 | 4 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 2.38e-04 | 31 | 140 | 4 | M39897 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.39e-04 | 88 | 140 | 6 | M16004 | |
| Pathway | WP_APOPTOSIS_MODULATION_AND_SIGNALING | 3.05e-04 | 92 | 140 | 6 | M39664 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 3.84e-04 | 35 | 140 | 4 | M48246 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 4.77e-04 | 37 | 140 | 4 | M39785 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 5.29e-04 | 38 | 140 | 4 | M27255 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.31e-04 | 102 | 140 | 6 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 5.60e-04 | 103 | 140 | 6 | M39434 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 5.89e-04 | 17 | 140 | 3 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 7.01e-04 | 18 | 140 | 3 | M47539 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 7.10e-04 | 41 | 140 | 4 | MM1493 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 7.71e-04 | 151 | 140 | 7 | M39801 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 7.86e-04 | 73 | 140 | 5 | M39837 | |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 8.27e-04 | 19 | 140 | 3 | M39450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 8.27e-04 | 19 | 140 | 3 | M47450 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 9.60e-04 | 5 | 140 | 2 | MM16637 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_EXTRINSIC_APOPTOTIC_PATHWAY_XIAP | 9.60e-04 | 5 | 140 | 2 | M48992 | |
| Pathway | REACTOME_SULFIDE_OXIDATION_TO_SULFATE | 9.60e-04 | 5 | 140 | 2 | MM14617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 9.66e-04 | 20 | 140 | 3 | M47617 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.06e-03 | 78 | 140 | 5 | M973 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586 | 1.10e-03 | 46 | 140 | 4 | M39661 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 1.16e-03 | 314 | 140 | 10 | M39428 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.25e-03 | 120 | 140 | 6 | M48233 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.29e-03 | 22 | 140 | 3 | M47616 | |
| Pathway | REACTOME_SULFIDE_OXIDATION_TO_SULFATE | 1.43e-03 | 6 | 140 | 2 | M26980 | |
| Pathway | REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH | 1.43e-03 | 6 | 140 | 2 | M27883 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.43e-03 | 6 | 140 | 2 | MM14521 | |
| Pathway | REACTOME_XENOBIOTICS | 1.47e-03 | 23 | 140 | 3 | M5372 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION | 1.47e-03 | 23 | 140 | 3 | M47772 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.47e-03 | 23 | 140 | 3 | MM15634 | |
| Pathway | WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING | 1.50e-03 | 218 | 140 | 8 | M42569 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | HSP90B2P JAK1 TBC1D1 VEGFC DDIT4 HIF3A IFNA8 IFNA14 IFNA17 EIF4B | 1.54e-03 | 326 | 140 | 10 | MM15917 |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.60e-03 | 126 | 140 | 6 | M45009 | |
| Pathway | WP_CANCER_PATHWAYS | TRAF6 JAK1 NFE2L2 ARNT2 POLK VEGFC CASP8 IFNA8 IFNA14 IFNA17 TGFBR2 ARNT GNA13 | 1.61e-03 | 507 | 140 | 13 | M48302 |
| Pathway | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | 1.64e-03 | 86 | 140 | 5 | MM15140 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 1.67e-03 | 24 | 140 | 3 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 1.67e-03 | 24 | 140 | 3 | M47576 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.74e-03 | 52 | 140 | 4 | MM14949 | |
| Pubmed | DCHS2 TRAF6 ZBTB38 PPRC1 MRPS35 FMNL2 LRP1B JAK1 CLPB SACS KLHL7 NFE2L2 ARID5B RNF10 CHD6 HSPA1A HSPA1B DOP1B DMXL2 COPA UBR4 ZNF521 ARHGEF10 CEP70 SENP6 TTC17 IFT122 PTGES3 RSBN1L | 5.67e-10 | 1285 | 204 | 29 | 35914814 | |
| Pubmed | DENND4A ERCC4 GON4L BUB1 XRN1 KMT2A MICAL3 DENND5A PPIP5K2 DMXL2 ARHGEF28 ARHGAP23 MYO19 DENND3 ARNT UPF2 IFT122 PATJ AGRN RSBN1L | 2.02e-09 | 650 | 204 | 20 | 38777146 | |
| Pubmed | PPRC1 GON4L SNX19 USP19 MAP3K4 PER2 PLEKHM2 STARD9 TBC1D1 DENND4B MICAL3 CHD6 DOP1B PPP1R9A EPG5 RSBN1 | 2.94e-09 | 407 | 204 | 16 | 12693553 | |
| Pubmed | RGPD1 PRDM2 BUB1 ARID5B XRN1 CHD6 HSPA1A HSPA1B ANKRD52 GOLGB1 UBR4 COPG2 ADNP RLF SKA3 CNOT1 | 4.28e-09 | 418 | 204 | 16 | 34709266 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DOCK11 ADGRB1 FMNL2 PRDM2 RPS6KC1 KMT2C DENND4B MYO3B ARID5B AHR CHD6 ALB HSPA8 DOP1B CFAP47 RARS1 MYO19 UBR4 PCDHB14 CNOT1 | 1.62e-08 | 736 | 204 | 20 | 29676528 |
| Pubmed | ERCC4 ATXN7L1 RGPD1 MRPS35 GON4L PRDM2 BLM KMT2C ATXN7 G3BP2 ARID5B XRN1 KMT2A CHD6 TADA3 KIF23 RARS1 COPA UBR4 ZNF521 ADNP RLF RSBN1 ARNT BRD7 FTH1 SCAF11 CNOT1 | 2.44e-08 | 1429 | 204 | 28 | 35140242 | |
| Pubmed | CBLL1 MRPS35 GON4L SQOR BLM JARID2 CHTF8 KMT2C CLPB ATXN7 XRN1 KMT2A CHD6 TADA3 GOLGB1 RARS1 PPP1R9A COPG2 IPO4 RSBN1 INTS6 ZNF277 EIF4B BRD7 SCAF11 PATJ AGRN RSBN1L | 6.45e-08 | 1497 | 204 | 28 | 31527615 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 23352621 | ||
| Pubmed | Analysis of Ah receptor-ARNT and Ah receptor-ARNT2 complexes in vitro and in cell culture. | 1.99e-07 | 3 | 204 | 3 | 18096572 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 8657146 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 1.99e-07 | 3 | 204 | 3 | 15129916 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 28025138 | ||
| Pubmed | KIFBP CAND2 MRPS35 ANKLE2 SNX19 NSRP1 BLM PASK CLPB SACS EIF2B4 USP48 HSPA1A HSPA1B ANKRD52 TADA3 TOP3B HSPA8 GOLGB1 DMXL2 UBR4 SLC6A15 IPO4 ARHGEF10 TTC17 IFT122 PTGES3 | 2.05e-07 | 1487 | 204 | 27 | 33957083 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A DOCK11 MELK NF1 STARD9 TBC1D1 XRN1 RNF10 KMT2A PPIP5K2 GOLGB1 DOP1B KIF23 ARHGEF28 DCP2 C2CD3 ARHGEF10 EIF4B SKA3 PATJ | 2.05e-07 | 861 | 204 | 20 | 36931259 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | KIFBP MELK BLM NF1 G3BP2 BUB1 DIAPH1 USP48 HSPA8 GOLGB1 COPA COPG2 THAP1 INTS6 BRD7 CNOT1 | 4.01e-07 | 582 | 204 | 16 | 20467437 |
| Pubmed | 7.88e-07 | 13 | 204 | 4 | 38660315 | ||
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 7.92e-07 | 4 | 204 | 3 | 18299791 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 18379898 | ||
| Pubmed | The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor. | 7.92e-07 | 4 | 204 | 3 | 11259606 | |
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 7.92e-07 | 4 | 204 | 3 | 22956628 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIFBP SPAG1 DENND4A TRAF6 CAND2 MRPS35 ANKLE2 FMNL2 MELK BLM SLC9C1 NF1 KLHL7 TBC1D1 EIF2B4 BUB1 WDR35 PPIP5K2 SPAG16 MYO19 IPO4 TTI1 IFT122 CNOT1 | 1.02e-06 | 1321 | 204 | 24 | 27173435 |
| Pubmed | 1.10e-06 | 14 | 204 | 4 | 22095711 | ||
| Pubmed | CBLL1 RNF187 USP19 KMT2C NF1 CLPB ARID5B XRN1 AHR KMT2A SLBP TADA3 KIF23 ARHGEF28 UBR4 RLF INTS6 ARNT UPF2 GNA13 EIF4B BRD7 SKA3 CNOT1 | 1.10e-06 | 1327 | 204 | 24 | 32694731 | |
| Pubmed | CBLL1 KIFBP DOCK11 RGPD1 NF1 KLHL7 G3BP2 DIAPH1 TOP3B HSPA8 GOLGB1 DMXL2 KIF23 PPP1R9A UBR4 IPO4 ADNP BRD7 CNOT1 AGRN | 1.17e-06 | 963 | 204 | 20 | 28671696 | |
| Pubmed | SPAG1 DENND4A ARMC3 PPRC1 RGPD1 MRPS35 ANKLE2 RPS6KC1 SACS ATXN7 STARD9 XRN1 KMT2A CHD6 PPIP5K2 TOP3B HSPA8 GOLGB1 COPA PPP1R9A UBR4 C2CD3 GNA13 EIF4B IFT122 | 1.39e-06 | 1442 | 204 | 25 | 35575683 | |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 1.97e-06 | 5 | 204 | 3 | 11584023 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 1.97e-06 | 5 | 204 | 3 | 16906134 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 11568360 | ||
| Pubmed | Organogenesis of the liver, thymus and spleen is affected in jumonji mutant mice. | 1.97e-06 | 5 | 204 | 3 | 9376320 | |
| Pubmed | Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. | 1.97e-06 | 5 | 204 | 3 | 9545558 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 17182002 | ||
| Pubmed | G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor. | 1.97e-06 | 5 | 204 | 3 | 19390533 | |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 3.93e-06 | 6 | 204 | 3 | 15963462 | |
| Pubmed | K63-Ubiquitylation and TRAF6 Pathways Regulate Mammalian P-Body Formation and mRNA Decapping. | 3.93e-06 | 6 | 204 | 3 | 27315556 | |
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 3.93e-06 | 6 | 204 | 3 | 25281747 | |
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 16397188 | ||
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 11025203 | ||
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 3.93e-06 | 6 | 204 | 3 | 7988674 | |
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 9305631 | ||
| Pubmed | Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. | 3.93e-06 | 6 | 204 | 3 | 19286559 | |
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 3.93e-06 | 6 | 204 | 3 | 11032181 | |
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 23275542 | ||
| Pubmed | Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system. | 3.93e-06 | 6 | 204 | 3 | 12853476 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 4.25e-06 | 208 | 204 | 9 | 33230847 | |
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 5.17e-06 | 20 | 204 | 4 | 11694501 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HSP90B2P DOCK11 RPS6KC1 NF1 CLPB SCP2 CHD6 ALB TOP3B COPA ARHGAP23 UBR4 INTS6 | 5.31e-06 | 475 | 204 | 13 | 31040226 |
| Pubmed | 6.19e-06 | 277 | 204 | 10 | 30745168 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CBLL1 ZBTB38 ZSCAN25 NSRP1 BLM SACS CHD6 ALB PPIP5K2 HSPA8 DMXL2 COPA RNPC3 ZNF521 ADNP INTS6 UPF2 FTH1 CNOT1 AGRN | 6.67e-06 | 1082 | 204 | 20 | 38697112 |
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 6.84e-06 | 7 | 204 | 3 | 10205060 | |
| Pubmed | 6.84e-06 | 7 | 204 | 3 | 15319539 | ||
| Pubmed | 6.84e-06 | 7 | 204 | 3 | 27782878 | ||
| Pubmed | GON4L XRN1 DIAPH1 SCP2 KMT2A SLBP MICAL3 CHD6 ALB USP48 KIF23 RLF C2CD3 SKA3 CNOT1 | 7.12e-06 | 645 | 204 | 15 | 25281560 | |
| Pubmed | 7.19e-06 | 222 | 204 | 9 | 37071664 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATXN7L1 ZP3 NSRP1 KMT2C ATXN7 TBC1D1 EIF2B4 ARID5B SCP2 ACSF3 MICAL3 CHD6 DENND5A POLK GOLGB1 PPP1R9A RLF ANKRD44 INTS6 TTC17 SCAF11 IFT122 PATJ CNOT1 | 7.84e-06 | 1489 | 204 | 24 | 28611215 |
| Pubmed | 8.01e-06 | 225 | 204 | 9 | 12168954 | ||
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 11782478 | ||
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 1.09e-05 | 8 | 204 | 3 | 9122205 | |
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 25202009 | ||
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 23973223 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MRPS35 KLHL7 EIF2B4 DIAPH1 KMT2A CHD6 ALB PPIP5K2 HSPA1A HSPA8 RARS1 COPA UBR4 COPG2 IPO4 ADNP RSBN1 UPF2 MEIOC PTGES3 AGRN RSBN1L | 1.13e-05 | 1318 | 204 | 22 | 30463901 |
| Pubmed | FMNL2 SQOR NSRP1 JAK1 EIF2B4 KMT2A HSPA1A HSPA8 KIF23 RARS1 COPA UBR4 ARHGEF10 SCAF11 | 1.42e-05 | 601 | 204 | 14 | 33658012 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | KIFBP TRAF6 CAND2 LYPLAL1 ADGRB1 SMYD5 MELK PTH2R JARID2 NF1 PLEKHM2 G3BP2 RNF10 TOP3B DOP1B DMXL2 RARS1 ZNF496 CYP2R1 BRD7 SCAF11 | 1.49e-05 | 1242 | 204 | 21 | 30973865 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | USP19 PRDM2 BLM PASK NF1 PTPRC ATXN7 KMT2A MICAL3 HSPA8 KIF23 COPA EIF4B FTH1 SENP6 SCAF11 | 1.51e-05 | 774 | 204 | 16 | 15302935 |
| Pubmed | Redox DAPK1 destabilizes Pellino1 to govern inflammation-coupling tubular damage during septic AKI. | 1.63e-05 | 9 | 204 | 3 | 33052227 | |
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 21763498 | ||
| Pubmed | Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. | 1.63e-05 | 9 | 204 | 3 | 30381458 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CBLL1 MAGEA4 MRPS35 SQOR KLHL7 G3BP2 EIF2B4 ALB HSPA1B HSPA8 KIF23 RARS1 COPA DSG3 IPO4 ADNP UPF2 EIF4B SCAF11 PATJ RSBN1L | 1.78e-05 | 1257 | 204 | 21 | 36526897 |
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 1.81e-05 | 27 | 204 | 4 | 30936491 | |
| Pubmed | The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. | 1.81e-05 | 27 | 204 | 4 | 25456137 | |
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 1.81e-05 | 27 | 204 | 4 | 23027611 | |
| Pubmed | Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. | 2.11e-05 | 28 | 204 | 4 | 17277142 | |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 2.30e-05 | 143 | 204 | 7 | 30397336 | |
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 2.31e-05 | 10 | 204 | 3 | 11932435 | |
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 12832005 | ||
| Pubmed | Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. | 2.31e-05 | 10 | 204 | 3 | 17167422 | |
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 7906708 | ||
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 23921388 | ||
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 10069390 | ||
| Pubmed | SPAG1 CAND2 MRPS35 GON4L RNF10 HSPA1A HSPA1B TOP3B HSPA8 COPA IPO4 PTGES3 RSBN1L | 2.35e-05 | 547 | 204 | 13 | 37267103 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 SQOR PRDM2 BLM KMT2C MSANTD3 NFE2L2 ARID5B KMT2A CHD6 HSPA1B TADA3 HSPA8 ABCC1 KIF23 COPA ADNP THAP1 INTS6 ARNT SCAF11 | 2.72e-05 | 1294 | 204 | 21 | 30804502 |
| Pubmed | 2.79e-05 | 30 | 204 | 4 | 27568566 | ||
| Pubmed | 2.85e-05 | 100 | 204 | 6 | 10048485 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | ADGRB1 MRPS35 MELK USP19 CLPB G3BP2 ALB USP48 ANKRD52 TADA3 COPA PPP1R9A IPO4 SHQ1 ARHGEF10 GNA13 EIF4B CNOT1 | 2.97e-05 | 1005 | 204 | 18 | 19615732 |
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 3.17e-05 | 11 | 204 | 3 | 6444699 | |
| Pubmed | SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA. | 3.17e-05 | 11 | 204 | 3 | 34634033 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 3.17e-05 | 11 | 204 | 3 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 3.17e-05 | 11 | 204 | 3 | 15795237 | |
| Pubmed | 3.17e-05 | 11 | 204 | 3 | 9794439 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 3.17e-05 | 11 | 204 | 3 | 27708256 | |
| Pubmed | 3.17e-05 | 11 | 204 | 3 | 18835032 | ||
| Pubmed | 3.17e-05 | 11 | 204 | 3 | 24318877 | ||
| Pubmed | 3.17e-05 | 11 | 204 | 3 | 32234476 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 3.17e-05 | 11 | 204 | 3 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 3.17e-05 | 11 | 204 | 3 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 3.17e-05 | 11 | 204 | 3 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 3.17e-05 | 11 | 204 | 3 | 3456887 | |
| Pubmed | 3.17e-05 | 11 | 204 | 3 | 25310498 | ||
| Pubmed | SARM1 and TRAF6 bind to and stabilize PINK1 on depolarized mitochondria. | 3.17e-05 | 11 | 204 | 3 | 23885119 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 28273792 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 15466261 | ||
| Interaction | FAM83F interactions | 1.27e-06 | 36 | 198 | 6 | int:FAM83F | |
| Interaction | H2BC8 interactions | ERCC4 GON4L NSRP1 BLM ARID5B SEPTIN1 KMT2A SLBP CHD6 USP48 TADA3 KIF23 IPO4 ADNP EPG5 RLF BRD7 SENP6 SCAF11 | 4.35e-06 | 576 | 198 | 19 | int:H2BC8 |
| Interaction | CENPA interactions | KIFBP PRDM2 BLM DIAPH1 KMT2A CHD6 USP48 HSPA8 KIF23 SLC6A15 IPO4 RLF RSBN1 BRD7 SENP6 | 5.13e-06 | 377 | 198 | 15 | int:CENPA |
| Interaction | FASN interactions | CBLL1 RNF187 USP19 KMT2C NF1 PER2 ARID5B XRN1 AHR KMT2A HSPA1A TADA3 TOP3B HSPA8 FOXP3 ABCC1 KIF23 ARHGEF28 RARS1 UBR4 TIPARP RLF ARNT GNA13 EIF4B BRD7 CNOT1 | 5.65e-06 | 1062 | 198 | 27 | int:FASN |
| Interaction | RNF123 interactions | DOCK11 ADGRB1 FMNL2 USP19 PRDM2 RPS6KC1 KMT2C DENND4B MYO3B ARID5B AHR CHD6 ALB USP48 HSPA8 DOP1B CFAP47 RARS1 MYO19 UBR4 PCDHB14 ZNF277 CNOT1 | 6.69e-06 | 824 | 198 | 23 | int:RNF123 |
| Interaction | MAP2K1 interactions | TRAF6 MAP3K4 BLM NFE2L2 BUB1 DIAPH1 HSPA1A HSPA8 FOXP3 TIPARP TGFBR2 ZNF277 SKA3 | 6.98e-06 | 293 | 198 | 13 | int:MAP2K1 |
| Interaction | DNA2 interactions | 1.27e-05 | 79 | 198 | 7 | int:DNA2 | |
| Interaction | USP27X interactions | 2.94e-05 | 37 | 198 | 5 | int:USP27X | |
| Interaction | LHPP interactions | 2.94e-05 | 37 | 198 | 5 | int:LHPP | |
| Interaction | XIAP interactions | TRAF6 RIPK1 USP19 BLM HSPA1A OSTM1 SEPTIN4 CASP4 CASP8 TIPARP XAF1 | 3.10e-05 | 244 | 198 | 11 | int:XIAP |
| Interaction | H3-4 interactions | USP19 PRDM2 JAK1 KMT2C KMT2A CHD6 POLK TADA3 HSPA8 IPO4 ADNP DENND3 ELMO3 BRD7 TTC17 | 3.88e-05 | 448 | 198 | 15 | int:H3-4 |
| Interaction | MAD2L1 interactions | ERCC4 BUB1 WDR35 PPIP5K2 HSPA1A HSPA8 FOXP3 PPP1R9A ADNP TIPARP ARNT | 4.17e-05 | 252 | 198 | 11 | int:MAD2L1 |
| Interaction | KDM1A interactions | KIFBP PRDM2 NFE2L2 BUB1 ARID5B XRN1 RNF10 CHD6 HSPA1A HSPA1B ANKRD52 TADA3 GOLGB1 FOXP3 UBR4 COPG2 ADNP TIPARP RLF ANKEF1 CEP70 SKA3 CNOT1 | 5.42e-05 | 941 | 198 | 23 | int:KDM1A |
| Interaction | CDH1 interactions | CBLL1 SPAG1 HEMGN FMNL2 MSANTD3 NFE2L2 BUB1 XRN1 DIAPH1 HSPA1A HSPA8 GOLGB1 RARS1 ARHGAP23 CASP8 COPG2 GNA13 EIF4B FTH1 PATJ | 7.27e-05 | 768 | 198 | 20 | int:CDH1 |
| Interaction | MSH6 interactions | ZBTB38 BLM POLK HSPA1A HSPA8 FOXP3 KIF23 CASP4 ARFGEF1 TIPARP PTGES3 | 8.01e-05 | 271 | 198 | 11 | int:MSH6 |
| Interaction | DNAJC7 interactions | USP19 NF1 SACS WDR35 HSPA1A HSPA1B HSPA8 DMXL2 IPO4 TIPARP TGFBR2 BRD7 IFT122 PTGES3 | 8.40e-05 | 425 | 198 | 14 | int:DNAJC7 |
| Interaction | COPZ1 interactions | 8.64e-05 | 143 | 198 | 8 | int:COPZ1 | |
| Interaction | ZFC3H1 interactions | 9.23e-05 | 185 | 198 | 9 | int:ZFC3H1 | |
| Interaction | NOLC1 interactions | ANKLE2 NF1 G3BP2 POLK HSPA1A KIF23 COPA RNPC3 COPG2 TIPARP BRD7 SKA3 | 9.40e-05 | 325 | 198 | 12 | int:NOLC1 |
| Interaction | TRIM38 interactions | 9.55e-05 | 47 | 198 | 5 | int:TRIM38 | |
| Interaction | TTC22 interactions | 9.60e-05 | 2 | 198 | 2 | int:TTC22 | |
| Interaction | SIM2 interactions | 9.73e-05 | 25 | 198 | 4 | int:SIM2 | |
| Interaction | MUS81 interactions | 1.02e-04 | 109 | 198 | 7 | int:MUS81 | |
| Interaction | CCDC142 interactions | 1.07e-04 | 10 | 198 | 3 | int:CCDC142 | |
| Interaction | CCDC117 interactions | 1.14e-04 | 26 | 198 | 4 | int:CCDC117 | |
| Interaction | ELP3 interactions | 1.15e-04 | 149 | 198 | 8 | int:ELP3 | |
| Interaction | BOD1L1 interactions | 1.15e-04 | 149 | 198 | 8 | int:BOD1L1 | |
| Interaction | SIGLECL1 interactions | 1.27e-04 | 113 | 198 | 7 | int:SIGLECL1 | |
| Interaction | SLX1A interactions | 1.33e-04 | 27 | 198 | 4 | int:SLX1A | |
| Interaction | INF2 interactions | RIPK1 AHR HSPA1A HSPA1B TOP3B HSPA8 KIF23 MYO19 TIPARP ARHGEF10 IFT122 | 1.37e-04 | 288 | 198 | 11 | int:INF2 |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 3.84e-05 | 25 | 140 | 4 | 504 | |
| GeneFamily | Caspases|Death effector domain containing|Ripoptosome|Death inducing signaling complex | 1.78e-04 | 3 | 140 | 2 | 1340 | |
| GeneFamily | Heat shock 70kDa proteins | 2.85e-04 | 17 | 140 | 3 | 583 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 8.75e-04 | 6 | 140 | 2 | 699 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.65e-03 | 110 | 140 | 5 | 420 | |
| GeneFamily | Interferons | 1.91e-03 | 32 | 140 | 3 | 598 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.01e-03 | 115 | 140 | 5 | 769 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.28e-03 | 34 | 140 | 3 | 487 | |
| GeneFamily | Ankyrin repeat domain containing | 2.81e-03 | 242 | 140 | 7 | 403 | |
| GeneFamily | Septins | 4.39e-03 | 13 | 140 | 2 | 732 | |
| GeneFamily | Caspases|Caspase recruitment domain containing | 4.39e-03 | 13 | 140 | 2 | 468 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | PPRC1 JARID2 PER2 SACS NFE2L2 ARID5B AHR SLBP PPIP5K2 VEGFC DDIT4 KIF23 CASP8 ADNP TIPARP RSBN1 SCAF11 BICRAL | 2.51e-11 | 300 | 203 | 18 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ANKLE2 MELK MAP3K4 BLM JARID2 SACS ARNT2 ARID5B MICAL3 DENND5A PPIP5K2 DOP1B VEGFC ABCC1 DMXL2 KIF23 ARFGEF1 CASP8 ADNP TIPARP RLF TGFBR2 RSBN1 C2CD3 UPF2 ARHGEF10 BICRAL | 6.53e-10 | 856 | 203 | 27 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DENND4A ZBTB38 DOCK11 ANKLE2 PRDM2 JAK1 JARID2 KMT2C PTPRC SACS ATXN7 TBC1D1 G3BP2 DENND4B XRN1 DIAPH1 SEPTIN1 AHR KMT2A HSPA8 DDIT4 OSTM1 UBR4 DCP2 CASP8 RGS16 EPG5 ANKRD44 TGFBR2 GNA13 EIF4B LPIN2 SENP6 SCAF11 PTGES3 CNOT1 | 1.12e-09 | 1492 | 203 | 36 | M40023 |
| Coexpression | SENESE_HDAC1_TARGETS_UP | SPAG1 ZBTB38 SNX19 PRDM2 NFE2L2 G3BP2 BUB1 VEGFC COPA DCP2 POMGNT1 SLC6A15 EPG5 TGFBR2 GNA13 CNOT1 | 5.20e-07 | 451 | 203 | 16 | M14973 |
| Coexpression | OSMAN_BLADDER_CANCER_UP | RPS6KC1 BLM KMT2C PTPRC KLHL7 NFE2L2 SCP2 ZER1 RNPC3 RSBN1 INTS6 BRD7 TTC17 SCAF11 | 3.38e-06 | 402 | 203 | 14 | M5275 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ZBTB38 LYPLAL1 NSRP1 RPS6KC1 BLM SACS SCP2 PPIP5K2 POLK USP48 GOLGB1 KIF23 OSTM1 ARFGEF1 THAP1 RLF CEP70 SCAF11 | 3.93e-06 | 656 | 203 | 18 | M18979 |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | KIFBP SNX19 PRDM2 JAK1 CLPB PLEKHM2 ATXN7 TBC1D1 SCP2 KMT2A SLBP USP48 TADA3 HSPA8 NBPF3 UBR4 POMGNT1 RLF C2CD3 FTH1 | 5.16e-06 | 807 | 203 | 20 | M14594 |
| Coexpression | ZHONG_PFC_C4_UNKNOWN_INP | 6.07e-06 | 89 | 203 | 7 | M39084 | |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | RIPK1 NFE2L2 ARID5B SLBP VEGFC DDIT4 KIF23 RARS1 CASP8 ADNP TIPARP | 1.71e-05 | 289 | 203 | 11 | M13630 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MELK BLM JARID2 ARID5B MICAL3 DENND5A DOP1B VEGFC KIF23 ARFGEF1 CASP8 TIPARP C2CD3 UPF2 | 1.79e-05 | 466 | 203 | 14 | M13522 |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 1.89e-05 | 71 | 203 | 6 | M12482 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 2.40e-05 | 74 | 203 | 6 | MM768 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN | 2.76e-05 | 200 | 203 | 9 | M4994 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 2.76e-05 | 200 | 203 | 9 | M7449 | |
| Coexpression | GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP | 3.68e-05 | 160 | 203 | 8 | M6863 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_PR_DN | 3.83e-05 | 49 | 203 | 5 | M10412 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZBTB38 ATXN7L1 FMNL2 JAK1 JARID2 KMT2C PTPRC PER2 ATXN7 TBC1D1 ARID5B PPIP5K2 HSPA1A HSPA1B RNPC3 TIPARP TGFBR2 ARNT LPIN2 | 3.96e-05 | 854 | 203 | 19 | M1533 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | KIFBP ZBTB38 CAND2 SMYD5 LDHD PER2 SEPTIN1 ACSF3 TTC22 ABCC1 ZNF521 CASP8 IPO4 MDGA1 CNOT1 | 4.50e-05 | 574 | 203 | 15 | M8215 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | FMNL2 PTH2R USP19 RPS6KC1 JAK1 PTPRC CLPB ZER1 CHD6 GOLGB1 DDIT4 MYO19 CASP8 RGS16 TMED3 CYP2R1 ZNF277 LPIN2 FTH1 SCAF11 | 4.73e-05 | 942 | 203 | 20 | M8144 |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 5.28e-05 | 10 | 203 | 3 | MM1243 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | KIFBP RIPK1 MRPS35 MAP3K4 SACS BUB1 HSPA8 VEGFC EIF4B PTGES3 | 5.55e-05 | 272 | 203 | 10 | M15123 |
| Coexpression | GENTILE_RESPONSE_CLUSTER_D3 | 5.63e-05 | 53 | 203 | 5 | M11338 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZBTB38 ATXN7L1 FMNL2 JAK1 JARID2 KMT2C PTPRC PER2 ATXN7 TBC1D1 ARID5B PPIP5K2 HSPA1A HSPA1B RNPC3 TIPARP TGFBR2 ARNT LPIN2 | 6.65e-05 | 888 | 203 | 19 | MM1018 |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 7.12e-05 | 130 | 203 | 7 | M17428 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | KIFBP ZBTB38 CAND2 SMYD5 LDHD PER2 SEPTIN1 ACSF3 TTC22 ABCC1 ZNF521 CASP8 IPO4 MDGA1 CNOT1 | 7.39e-05 | 600 | 203 | 15 | MM1025 |
| Coexpression | JIANG_MELANOMA_TRM1_CD8 | 7.51e-05 | 177 | 203 | 8 | M48965 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 1.23e-04 | 190 | 203 | 8 | M8457 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | ZBTB38 FMNL2 JAK1 NF1 G3BP2 VEGFC COPA DCP2 POMGNT1 SLC6A15 RGS16 TGFBR2 GNA13 | 1.39e-04 | 495 | 203 | 13 | M8451 |
| Coexpression | PODAR_RESPONSE_TO_ADAPHOSTIN_UP | 1.60e-04 | 148 | 203 | 7 | M16336 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | SQOR RPS6KC1 JARID2 RTP3 ARID5B XRN1 SCP2 DENND5A POLK VEGFC DDIT4 OSTM1 ARFGEF1 DENND3 RLF TGFBR2 NETO2 GNA13 XAF1 AGRN | 1.64e-04 | 1033 | 203 | 20 | M4196 |
| Coexpression | GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP | 1.69e-04 | 199 | 203 | 8 | M8347 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.69e-04 | 199 | 203 | 8 | M9568 | |
| Coexpression | GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN | 1.69e-04 | 199 | 203 | 8 | M9959 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 1.69e-04 | 199 | 203 | 8 | M7325 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_DN | 1.69e-04 | 199 | 203 | 8 | M5565 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 1.75e-04 | 200 | 203 | 8 | M7750 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 1.75e-04 | 200 | 203 | 8 | M6240 | |
| Coexpression | GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN | 1.75e-04 | 200 | 203 | 8 | M9050 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN | 1.75e-04 | 200 | 203 | 8 | M9079 | |
| Coexpression | HELLER_SILENCED_BY_METHYLATION_DN | 1.89e-04 | 107 | 203 | 6 | M3185 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 2.10e-04 | 38 | 203 | 4 | M1751 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.32e-04 | 39 | 203 | 4 | M41095 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | CBLL1 TRAF6 GON4L RPS6KC1 PER2 NFE2L2 AHR GOLGB1 DDIT4 TIPARP RLF UPF2 ZNF277 GNA13 FTH1 SENP6 TTC17 | 2.42e-04 | 822 | 203 | 17 | M6782 |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_DN | 2.80e-04 | 115 | 203 | 6 | M7484 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | DENND4A PRDM2 KMT2C NF1 PTPRC KMT2A GOLGB1 ARFGEF1 EPG5 RLF ANKRD44 | 1.28e-09 | 188 | 205 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | PRDM2 KMT2C PTPRC XRN1 KMT2A GOLGB1 CASP8 ANKRD44 BRD7 SCAF11 XAF1 | 2.46e-09 | 200 | 205 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | PRDM2 JAK1 KMT2C G3BP2 ARID5B XRN1 DIAPH1 KMT2A GOLGB1 XAF1 CNOT1 | 2.46e-09 | 200 | 205 | 11 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | CV-Severe-6|Severe / Virus stimulation, Condition and Cluster | 3.05e-07 | 194 | 205 | 9 | d33be6ed1de907aeea0c2dce09796556b8efdd4e | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia|World / Primary Cells by Cluster | 3.05e-07 | 194 | 205 | 9 | 1445b7611c2b1ab9b320f330d17d70117892cc28 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.47e-07 | 197 | 205 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 3.62e-07 | 198 | 205 | 9 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-06 | 185 | 205 | 8 | a86a3a1a187a4d8d7762bc6d3dcb22c982178d22 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-06 | 132 | 205 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.89e-06 | 190 | 205 | 8 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.25e-06 | 193 | 205 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.25e-06 | 193 | 205 | 8 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | Non-neuronal-Non-dividing|World / Primary Cells by Cluster | 3.38e-06 | 194 | 205 | 8 | 0add09d97192b34bd506209ab5f1a77182f498fc | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.38e-06 | 194 | 205 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.78e-06 | 197 | 205 | 8 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.07e-06 | 199 | 205 | 8 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.07e-06 | 199 | 205 | 8 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.41e-06 | 157 | 205 | 7 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 1.26e-05 | 167 | 205 | 7 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.31e-05 | 168 | 205 | 7 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 1.36e-05 | 169 | 205 | 7 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-05 | 170 | 205 | 7 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 171 | 205 | 7 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-05 | 174 | 205 | 7 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-05 | 174 | 205 | 7 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 175 | 205 | 7 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.77e-05 | 176 | 205 | 7 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 179 | 205 | 7 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-05 | 180 | 205 | 7 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-05 | 180 | 205 | 7 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-05 | 180 | 205 | 7 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 182 | 205 | 7 | 3948422707d6d5e021bcd7158e2eb69143613f62 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.19e-05 | 182 | 205 | 7 | 9ba85f621a846531a2a7861e9df695d288c9e149 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 182 | 205 | 7 | fe46819c153a81911864473badc794f243705f98 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.19e-05 | 182 | 205 | 7 | deb53a4f84e4cd5c3b4180a4ac43249da9d738f7 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.43e-05 | 185 | 205 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | Dendritic_Cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.52e-05 | 186 | 205 | 7 | 1d52912bd17e232cf39b2423a4d93585c164ba34 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 188 | 205 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Mega-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 2.70e-05 | 188 | 205 | 7 | 8e80e0714883e5c5e372d933682c5b55ebef7e62 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_TCM|ICU-SEP / Disease, Lineage and Cell Type | 2.79e-05 | 189 | 205 | 7 | 9ed1cf4bb456780c1d1070de687bcabafd6287a3 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Treg|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.89e-05 | 190 | 205 | 7 | 632b9541371483d25948b6f033863c49f38e3603 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-05 | 190 | 205 | 7 | d0297d678498e346e56cf95fe9e3db7d3ad3b837 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-05 | 190 | 205 | 7 | 827a1f4e4ac4beada262f4fb965dd74a447a8f4f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-05 | 190 | 205 | 7 | da60bcc4b59d8e3719d8201387d567594059b1a4 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 191 | 205 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 191 | 205 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | severe_COVID-19-CD4+_Tcm|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.99e-05 | 191 | 205 | 7 | 1ec86eaf90411ed200dbf51ae0cb5ed8060a7ec7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-05 | 191 | 205 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-05 | 191 | 205 | 7 | a6c9df4cb4d09e0a91b3c8d7f3e091a7e95e6471 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.09e-05 | 192 | 205 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | COVID-19_Moderate-CD4+_Tcm|World / disease group, cell group and cell class | 3.09e-05 | 192 | 205 | 7 | 5f94310f1470487816fce697ffcdc2627fc66878 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.09e-05 | 192 | 205 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 390C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.09e-05 | 192 | 205 | 7 | 201d430af1e4fee7bc03baf0aca17db26f6f439a | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|World / disease group, cell group and cell class | 3.09e-05 | 192 | 205 | 7 | 3352f13a6e706991dcf3ec173587bb6aba36a385 | |
| ToppCell | 390C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.09e-05 | 192 | 205 | 7 | 15c1a0a0d07106118427135f166a1da710bf621a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.10e-05 | 130 | 205 | 6 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.19e-05 | 193 | 205 | 7 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 194 | 205 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 194 | 205 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_Tcm|COVID-19_Severe / Disease group, lineage and cell class | 3.41e-05 | 195 | 205 | 7 | 658751e384de50cdcb907d3740fb1a74004a517b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 195 | 205 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.41e-05 | 195 | 205 | 7 | e3e5c784e7b494434fb4f6f27e0af22b167842ef | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 195 | 205 | 7 | d6b8bc4204476220a64afe17e3b6b2ed59853284 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-05 | 196 | 205 | 7 | a1a1e4e4404a0c590edd07dfc9e7e1b6f720fb0f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-05 | 196 | 205 | 7 | 459408882babf1fb56b37dc52ec119ac0b0153a7 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-05 | 196 | 205 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 196 | 205 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 197 | 205 | 7 | cd54e6ad175529327fa0372033016b3b978dd452 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 197 | 205 | 7 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 197 | 205 | 7 | 1ffbbe44db0fd3ebd91ad16ab0b91153de5d7c6d | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.75e-05 | 198 | 205 | 7 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-Treg|ICU-NoSEP / Disease, condition lineage and cell class | 3.75e-05 | 198 | 205 | 7 | 1ed4dfe5565328cb0f7ef31e6b2f67dfbdf3e2ac | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.75e-05 | 198 | 205 | 7 | 33a3b279c9ff3b762e52d060dae062167ca2239b | |
| ToppCell | Severe_COVID-19-T/NK-CD4+_T_1|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.75e-05 | 198 | 205 | 7 | bc6b983fdb9547ef8a9e693bc15fced1b73e101f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-05 | 198 | 205 | 7 | fc8099bce80d84b29bdcc87064d4d8375dddfa0f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.75e-05 | 198 | 205 | 7 | 32ec322ed144c545014b191da5274d12feeaf96b | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.75e-05 | 198 | 205 | 7 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-05 | 198 | 205 | 7 | ec115c4a5dbc54206c72140aa0c8d6a7c29c5563 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.75e-05 | 198 | 205 | 7 | 1e281d8f0291e8cf814e9e5abd7f5860402a7c77 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.75e-05 | 198 | 205 | 7 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-05 | 198 | 205 | 7 | 74f190d8e337cff5ffb65d446cf784759e1c2a59 | |
| ToppCell | Caecum-T_cell-Th1|T_cell / Region, Cell class and subclass | 3.88e-05 | 199 | 205 | 7 | 13a80e6d3cf9c831edbe0644545071153e35f82b | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.88e-05 | 199 | 205 | 7 | b270d8274249103d3a1b4a4f8601c92fde007ed7 | |
| ToppCell | medial-2-Hematologic-CD4+_Naive_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.88e-05 | 199 | 205 | 7 | 231a539899e2b76215da3e96a6755799f722e278 | |
| ToppCell | Bronchial_Biopsy-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.88e-05 | 199 | 205 | 7 | be916332291ea48e244c05ab1855f9fcd718ac54 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.88e-05 | 199 | 205 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.88e-05 | 199 | 205 | 7 | fbbac5e9153e813db848d498eb715aa208568d8d | |
| ToppCell | medial-Hematologic-CD4+_Naive_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.88e-05 | 199 | 205 | 7 | 6a896a447388fd525cff207e17a5371c0f6b38cb | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.88e-05 | 199 | 205 | 7 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | medial-Hematologic-CD4+_Naive_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.88e-05 | 199 | 205 | 7 | a54c35a646ae23bdd35c278ffb027408cf8dd553 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.88e-05 | 199 | 205 | 7 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.88e-05 | 199 | 205 | 7 | 8ee3dbc0a92de5f3865e5484970ae2aab7d1a956 | |
| ToppCell | TCGA-Bladder-Primary_Tumor|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.88e-05 | 199 | 205 | 7 | c403e28def2e14f5931cd73b4fb9a4078c0439f8 | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 4.00e-05 | 200 | 205 | 7 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 4.00e-05 | 200 | 205 | 7 | 372fe9018481a4e9ac6ab3af43705a48238c4376 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.00e-05 | 200 | 205 | 7 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 4.00e-05 | 200 | 205 | 7 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | severe-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.00e-05 | 200 | 205 | 7 | e83558090a079dd9e40e0d3b5d9917fbd2695ec4 | |
| Drug | Mercury | ZBTB38 PPRC1 ZP3 NSRP1 RPS6KC1 BLM RTP3 NFE2L2 BUB1 AHR ALB HSPA1A HSPA1B HSPA8 ABCC1 ARHGEF28 HIF3A IFNA8 ARNT SENP6 | 3.10e-07 | 584 | 203 | 20 | ctd:D008628 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | CBLL1 PPRC1 PRDM2 MAP3K4 JARID2 ATXN7 NFE2L2 ARID5B ADNP TIPARP RSBN1 | 8.52e-07 | 184 | 203 | 11 | 2321_DN |
| Drug | Silymarin | TRAF6 RIPK1 JAK1 NFE2L2 AHR SCP2 ALB HSPA1B HSPA8 ABCC1 CASP8 | 8.98e-07 | 185 | 203 | 11 | ctd:D012838 |
| Drug | Vitamin K 3 | PPRC1 GON4L SQOR JAK1 JARID2 LDHD PER2 CLPB NFE2L2 BUB1 AHR SLBP ALB HSPA1A HSPA1B DDIT4 KIF23 MYO19 PPP1R9A UBR4 CASP4 HIF3A THAP1 RGS16 TIPARP TGFBR2 CYP2R1 EIF4B SKA3 | 2.24e-06 | 1249 | 203 | 29 | ctd:D024483 |
| Drug | Cacodylic Acid | CAPN9 NFE2L2 AHR HSPA1B HSPA8 VEGFC ABCC1 NPY5R CASP8 SHQ1 TGFBR2 FTH1 | 4.24e-06 | 261 | 203 | 12 | ctd:D002101 |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 6.65e-06 | 185 | 203 | 10 | 1114_DN | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | RIPK1 PLEKHM2 ZER1 USP48 DMXL2 COPA PPP1R9A ZNF35 GNA13 PATJ | 1.10e-05 | 196 | 203 | 10 | 6888_UP |
| Drug | Chlorpromazine | ACP6 ERCC4 LYPLAL1 TSTD1 NFE2L2 EIF2B4 AHR ACSF3 SLX1A DIPK1C APOF TIPARP EPG5 ARHGEF10 FTH1 TTI1 AGRN | 1.33e-05 | 564 | 203 | 17 | ctd:D002746 |
| Drug | formetanate | 1.37e-05 | 6 | 203 | 3 | ctd:C100163 | |
| Drug | Buthionine Sulfoximine | JAK1 NFE2L2 EIF2B4 ALB HSPA8 FOXP3 ABCC1 CASP4 CASP8 TGFBR2 ARNT FTH1 | 2.10e-05 | 306 | 203 | 12 | ctd:D019328 |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 1.02e-08 | 5 | 200 | 4 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.66e-06 | 61 | 200 | 6 | C1961102 | |
| Disease | Leukemia, Myelocytic, Acute | 2.52e-05 | 173 | 200 | 8 | C0023467 | |
| Disease | spinocerebellar ataxia type 7 (implicated_via_orthology) | 4.57e-05 | 2 | 200 | 2 | DOID:0050958 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | LRP1B TSTD1 JARID2 MYO3B ARNT2 SLBP ARHGEF28 RGS16 TMED3 TGFBR2 PATJ | 2.56e-04 | 447 | 200 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | Cranioectodermal dysplasia | 2.72e-04 | 4 | 200 | 2 | cv:C4551571 | |
| Disease | melanoma | 3.07e-04 | 248 | 200 | 8 | C0025202 | |
| Disease | Prostatic Neoplasms | LRP1B JAK1 KMT2C PTPRC NFE2L2 AHR KMT2A CHD6 POLK HSPA1A TGFBR2 SENP6 PATJ | 3.19e-04 | 616 | 200 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | LRP1B JAK1 KMT2C PTPRC NFE2L2 AHR KMT2A CHD6 POLK HSPA1A TGFBR2 SENP6 PATJ | 3.19e-04 | 616 | 200 | 13 | C0376358 |
| Disease | L2 Acute Lymphoblastic Leukemia | 3.70e-04 | 50 | 200 | 4 | C0023453 | |
| Disease | Bladder Neoplasm | 3.98e-04 | 140 | 200 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.13e-04 | 141 | 200 | 6 | C0005684 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 4.30e-04 | 52 | 200 | 4 | C0023452 | |
| Disease | CRANIOECTODERMAL DYSPLASIA 1 | 4.51e-04 | 5 | 200 | 2 | C0432235 | |
| Disease | malignant astrocytoma (is_marker_for) | 4.92e-04 | 23 | 200 | 3 | DOID:3069 (is_marker_for) | |
| Disease | leukemia | 5.33e-04 | 55 | 200 | 4 | C0023418 | |
| Disease | Carcinoma, Pancreatic Ductal | 5.59e-04 | 24 | 200 | 3 | C0887833 | |
| Disease | laryngeal carcinoma (is_marker_for) | 6.74e-04 | 6 | 200 | 2 | DOID:2600 (is_marker_for) | |
| Disease | Liver Cirrhosis | 6.96e-04 | 103 | 200 | 5 | C0023890 | |
| Disease | Acute monocytic leukemia | 7.11e-04 | 26 | 200 | 3 | C0023465 | |
| Disease | Micronuclei, Chromosome-Defective | 7.11e-04 | 26 | 200 | 3 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 7.11e-04 | 26 | 200 | 3 | C1449862 | |
| Disease | Fibrosis, Liver | 7.59e-04 | 105 | 200 | 5 | C0239946 | |
| Disease | Hereditary Diffuse Gastric Cancer | 9.17e-04 | 293 | 200 | 8 | C1708349 | |
| Disease | Stomach Neoplasms | 1.00e-03 | 297 | 200 | 8 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.07e-03 | 300 | 200 | 8 | C0024623 | |
| Disease | Malignant neoplasm of breast | MAGEA4 NF1 PTPRC PER2 G3BP2 AHR SCP2 HSPA1B GOLGB1 FOXP3 VEGFC ABCC1 UBR4 CASP8 EPG5 ZNF277 ANKEF1 | 1.09e-03 | 1074 | 200 | 17 | C0006142 |
| Disease | pyridoxate measurement | 1.20e-03 | 31 | 200 | 3 | EFO_0010527 | |
| Disease | Rheumatoid Arthritis | 1.24e-03 | 174 | 200 | 6 | C0003873 | |
| Disease | sleep duration, circadian rhythm, excessive daytime sleepiness measurement, insomnia measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0004354, EFO_0005271, EFO_0007875, EFO_0007876 | |
| Disease | triacylglycerol 58:6 measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0010440 | |
| Disease | Lymphoid leukemia | 1.25e-03 | 8 | 200 | 2 | C0023448 | |
| Disease | stomach cancer (is_implicated_in) | 1.47e-03 | 72 | 200 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Major depression, single episode | 1.59e-03 | 9 | 200 | 2 | C0024517 | |
| Disease | Hepatic Insufficiency | 1.59e-03 | 9 | 200 | 2 | C1306571 | |
| Disease | PITUITARY DWARFISM I | 1.59e-03 | 9 | 200 | 2 | C0342573 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.65e-03 | 125 | 200 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.65e-03 | 125 | 200 | 5 | C1879321 | |
| Disease | reaction time measurement | JARID2 TBC1D1 ARID5B CHD6 ARHGAP23 PPP1R9A DCP2 CASP4 ZNF521 RGS16 ANKRD44 CCDC102B | 1.88e-03 | 658 | 200 | 12 | EFO_0008393 |
| Disease | pancreatic adenocarcinoma (is_marker_for) | 1.98e-03 | 10 | 200 | 2 | DOID:4074 (is_marker_for) | |
| Disease | Unipolar Depression | 2.02e-03 | 259 | 200 | 7 | C0041696 | |
| Disease | myositis | 2.34e-03 | 39 | 200 | 3 | EFO_0000783 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 2.42e-03 | 11 | 200 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | glycerophosphorylcholine measurement | 2.42e-03 | 11 | 200 | 2 | EFO_0020018 | |
| Disease | Liver carcinoma | 2.54e-03 | 507 | 200 | 10 | C2239176 | |
| Disease | Drug toxicity | 2.59e-03 | 84 | 200 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 2.59e-03 | 84 | 200 | 4 | C0041755 | |
| Disease | Carcinoma, Transitional Cell | 2.71e-03 | 41 | 200 | 3 | C0007138 | |
| Disease | Nodular glomerulosclerosis | 2.71e-03 | 41 | 200 | 3 | C0017667 | |
| Disease | cup-to-disc ratio measurement | 2.79e-03 | 430 | 200 | 9 | EFO_0006939 | |
| Disease | age at assessment, pelvic organ prolapse | 3.10e-03 | 43 | 200 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | Colorectal Carcinoma | KMT2C AMER2 NF1 SACS BUB1 ABCC1 ARFGEF1 CASP8 TGFBR2 ARNT XAF1 IGSF21 | 3.18e-03 | 702 | 200 | 12 | C0009402 |
| Disease | Diabetic Nephropathy | 3.31e-03 | 44 | 200 | 3 | C0011881 | |
| Disease | nevus count, cutaneous melanoma | 3.46e-03 | 91 | 200 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | adipose tissue measurement | 3.53e-03 | 45 | 200 | 3 | EFO_0004764 | |
| Disease | C-reactive protein measurement | DCHS2 CCDC168 JAK1 KLHL7 NFE2L2 TBC1D1 EIF2B4 RNF10 MICAL3 NBPF3 DMXL2 ARHGEF28 SLC6A15 HIF3A ANKRD44 SCAF11 PATJ | 3.64e-03 | 1206 | 200 | 17 | EFO_0004458 |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 3.94e-03 | 14 | 200 | 2 | C1858991 | |
| Disease | Saldino-Noonan Syndrome | 3.94e-03 | 14 | 200 | 2 | C0036069 | |
| Disease | pulmonary emphysema (is_marker_for) | 3.94e-03 | 14 | 200 | 2 | DOID:9675 (is_marker_for) | |
| Disease | white matter hyperintensity measurement | 4.69e-03 | 302 | 200 | 7 | EFO_0005665 | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 5.15e-03 | 16 | 200 | 2 | EFO_0008297 | |
| Disease | Synostotic Posterior Plagiocephaly | 5.15e-03 | 16 | 200 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 5.15e-03 | 16 | 200 | 2 | C4551902 | |
| Disease | Acrocephaly | 5.15e-03 | 16 | 200 | 2 | C0030044 | |
| Disease | Trigonocephaly | 5.15e-03 | 16 | 200 | 2 | C0265535 | |
| Disease | Scaphycephaly | 5.15e-03 | 16 | 200 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 5.15e-03 | 16 | 200 | 2 | C2931150 | |
| Disease | Metopic synostosis | 5.15e-03 | 16 | 200 | 2 | C1860819 | |
| Disease | lymphocyte count | CBLL1 ZBTB38 ZSCAN25 ANKLE2 FMNL2 JAK1 JARID2 PTPRC TBC1D1 ARID5B MICAL3 PPIP5K2 HSPA1A HSPA1B ABCC1 CASP8 HIF3A DENND3 RSBN1 | 5.22e-03 | 1464 | 200 | 19 | EFO_0004587 |
| Disease | Squamous cell carcinoma of the head and neck | 5.31e-03 | 52 | 200 | 3 | C1168401 | |
| Disease | Eye Abnormalities | 5.81e-03 | 17 | 200 | 2 | C0015393 | |
| Disease | Dystonia, Limb | 5.81e-03 | 17 | 200 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 5.81e-03 | 17 | 200 | 2 | C0393610 | |
| Disease | Brachycephaly | 5.81e-03 | 17 | 200 | 2 | C0221356 | |
| Disease | Hepatomegaly | 5.90e-03 | 54 | 200 | 3 | C0019209 | |
| Disease | Peripheral Nervous System Diseases | 5.90e-03 | 54 | 200 | 3 | C4721453 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 6.16e-03 | 170 | 200 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 6.34e-03 | 108 | 200 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | Dystonia, Paroxysmal | 6.51e-03 | 18 | 200 | 2 | C0393588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKKSEAQHEQPEDGC | 241 | O75528 | |
| EDFVTCLQLPENQKH | 736 | P35869 | |
| CKEHIEDFKQFEPND | 31 | Q9H2P0 | |
| LLGKNIVEFCHPEDQ | 391 | P27540 | |
| QEIPSLACEFKGDHL | 46 | Q9HCE0 | |
| ADQEEEAGPSCDKHV | 386 | Q8N7J2 | |
| EEQNLFIDVDCKHPE | 391 | O15013 | |
| QDVLAALECADVDPH | 836 | Q86XL3 | |
| PLLEKSHCIAEVEND | 306 | P02768 | |
| CFEDELKNPHAKIVN | 176 | Q5JVX7 | |
| EQVHDCEIIHGDIKP | 906 | O43683 | |
| AVLVKHTPGDQDCDE | 71 | P0CG13 | |
| RVENEAEKDLQCHAP | 96 | Q9NPI1 | |
| EPHEICDEDNFGAVI | 576 | O14514 | |
| ESTDALKLCPHEEFL | 101 | P49662 | |
| LPTEDCENEKEQAVH | 166 | Q13790 | |
| EVLYDGENHDCEEKP | 311 | Q9Y6D6 | |
| GENHDCEEKPQDIVQ | 316 | Q9Y6D6 | |
| LEEVEFCVEDKPGTH | 146 | O00468 | |
| VAFLEKAEPECQDHR | 126 | B4E2M5 | |
| PIFLRACEDAHDVKD | 151 | Q9NU02 | |
| PHAQDFLRAVCEEKI | 311 | Q4G176 | |
| PENRKLFHEQEVEKC | 306 | Q5W041 | |
| KEDDEHQVIIKSCNP | 1821 | Q8TDJ6 | |
| VNKEEAPHDCAAREV | 131 | Q8IU60 | |
| EIDCADKFGNTPLHV | 331 | Q8NB46 | |
| NGADPDFKCRHLQIE | 446 | O60610 | |
| KVEQNEERLSHDCEP | 501 | Q05D60 | |
| EPKEDCVHFLVLTDV | 56 | A2RUS2 | |
| LSEREFDPNKHCGVL | 286 | Q9ULK2 | |
| QPQDLLGKDILEFCH | 361 | Q9HBZ2 | |
| LGKDILEFCHPEDQS | 366 | Q9HBZ2 | |
| VSKPLEEEIHFNDAC | 21 | Q7Z401 | |
| LDVDEPISQLHKCAF | 301 | Q9UBG7 | |
| HLLNQAVGEEEVPKC | 186 | Q9H0G5 | |
| LENHEEPRDKEQCAE | 771 | Q9UL03 | |
| PKTEQDGHDIENECL | 176 | P23458 | |
| QDVVDGICKHNFDPR | 536 | Q7Z3E1 | |
| KNPFIHLDDDCVTEL | 276 | Q14680 | |
| DHSTVDKIFPCLDEL | 886 | Q8N1W1 | |
| QDLKLSCHVDAVPQE | 351 | Q8NFP4 | |
| IEGAHPEDKEITNIC | 671 | P32926 | |
| KESDDPVACIHFTAE | 21 | Q58FF3 | |
| NPFCELEETVEAAIH | 1201 | Q96RG2 | |
| SCLKDRHDFEFPQEE | 51 | P01570 | |
| HNDPESILKDDECTQ | 426 | Q9NPJ1 | |
| HDEDAGVICKDQRLP | 136 | P58215 | |
| AFQELCDHLELKPKD | 31 | Q7RTP6 | |
| CDKPTDHELDTQLKE | 496 | Q8NEZ4 | |
| AEHCINDIAFKPDGT | 11 | Q9HBG6 | |
| DEAQINCTKEEIHSP | 1036 | Q9NZR2 | |
| KSQHCKPEEGVEAQE | 6 | P43358 | |
| KVFEEPEDFLKHCQA | 206 | Q9BZS1 | |
| PEDFLKHCQADHLLD | 211 | Q9BZS1 | |
| CQAHEEKGIEELSDP | 741 | Q96S38 | |
| PHLVNCNEEKASDIA | 281 | Q9Y6X6 | |
| ELDGVEEKHFSQAPC | 831 | Q96H55 | |
| PAFLSDVEENHQECK | 2186 | Q9Y3R5 | |
| LCEHLDNAEQPELVF | 46 | Q9H9K5 | |
| AQAAEVPNEKCHLEA | 126 | A6PVY3 | |
| EFEHKRKELEQVCNP | 591 | P0DMV9 | |
| EDVFAAHPCTEEKAL | 441 | O15055 | |
| IPDDCKEHEFQEAVR | 26 | A0A0J9YXQ4 | |
| HVHDAQCENTPEKEL | 416 | Q16236 | |
| CLNIEDDPDIHEKPF | 851 | Q32MH5 | |
| NRELCDDEKEFIHFP | 146 | Q96H12 | |
| LDCPELKATADDFIH | 156 | Q8IXQ5 | |
| EIDCVDKDGNTPLHV | 331 | Q8N8A2 | |
| EFEGDPHCLRDVQKF | 311 | Q14344 | |
| NKAEPGTHLCIDVED | 246 | Q86WC4 | |
| ELDDPDDLQCKRGEH | 456 | Q9UI10 | |
| FDPDIHCGVIDLDTK | 341 | O15265 | |
| KVVPEEHFSEICQES | 126 | Q9BXL5 | |
| LCTVEDENDHAPEFI | 1816 | Q6V1P9 | |
| NILGEKDDTPVHFCD | 96 | Q75N03 | |
| LDAVCIIPENESDHE | 306 | Q9H094 | |
| LCVKDINDHSPTFLD | 121 | Q9Y5E9 | |
| LATDKNDPHLCDFIE | 121 | P02794 | |
| PQIDNEALFSCEVKH | 311 | Q96ID5 | |
| HSTEKVPCIEFDDDD | 281 | P54132 | |
| SQENCLEKFIPDHSE | 1046 | Q6AI39 | |
| RGKDHVCFAENPDTI | 236 | Q4AC94 | |
| PEKIPNHVFEIDEDC | 136 | Q5JSL3 | |
| KDLVQDCGFEHLVPV | 381 | Q8NHQ1 | |
| EKIEDVASHCLPQKD | 46 | Q8TD26 | |
| FELLSDPEDEHLCAN | 81 | Q9NX09 | |
| KECLVHQSEIFADRP | 96 | Q6VVX0 | |
| CTLIDKFDEHDGPVR | 41 | P53621 | |
| GNLPHDIDENELKEF | 336 | Q9UN86 | |
| NFHCILLVNPDDAEE | 426 | Q86WU2 | |
| PEDKAHVNVDIACAV | 1221 | Q3T8J9 | |
| NEALHFICDPDKREV | 46 | A6NN92 | |
| VLENSSREDKHECPF | 386 | Q96BJ8 | |
| EENPESKEAGLAHLC | 426 | Q9UBF2 | |
| CHDDDDKDPVLRVFD | 591 | Q6IQ26 | |
| GIPSDNEKHDLQDCV | 46 | Q9GZL8 | |
| NEKHDLQDCVEVSRP | 51 | Q9GZL8 | |
| ELHFEIKPHDDCTVE | 276 | Q14790 | |
| HVFDLKTLPVDFVEC | 721 | Q96PY5 | |
| CELDLAEGHQPQKVA | 136 | P12980 | |
| FKITNDCPEHLESID | 81 | Q5VWZ2 | |
| LEFFDSCVEKVHPEQ | 646 | O75064 | |
| HKFCLEENERPLEDQ | 1456 | Q03164 | |
| CPNAVVLFDEVDKAH | 446 | Q9H078 | |
| SCLKDRHDFEFPQEE | 51 | P32881 | |
| EFEHKRKELEQVCNP | 591 | P0DMV8 | |
| LIFPKHQEEKVQECE | 5281 | Q8NDH2 | |
| AHFDKVEICNLTPDA | 326 | O14815 | |
| AIYECPDKDEHLNKD | 421 | O14815 | |
| DICEFLNHVEDGLKD | 1106 | O75155 | |
| EVKTDVCTVHLPNDF | 536 | Q99590 | |
| PDIEVLKDLFCNEEG | 1056 | Q9NZJ4 | |
| QDLKLPGFVEESCEH | 156 | Q68D86 | |
| CEDPNEIPKIHEFEY | 2946 | Q6ZTR5 | |
| ESVFEEVFKLLECPH | 696 | Q8TEX9 | |
| GHKLRQADEQPFDLC | 1601 | Q5VV67 | |
| SCLKDRHDFGLPQEE | 51 | P01571 | |
| DYCEKHPEAAQEIEV | 581 | Q96EK5 | |
| AREEFTHTCPEDKEI | 221 | O15247 | |
| HLCDIKPENFAIRSD | 276 | Q0P6D2 | |
| SVVEENGEVKELHPC | 471 | Q13029 | |
| ACKTEDSDDIHFEPV | 1011 | P0DJD0 | |
| GLKHVPCVEDEDFIQ | 1101 | Q9HAU5 | |
| EFEHQQKELEKVCNP | 591 | P11142 | |
| LENETLNKEEDCHSP | 446 | P23588 | |
| CIPAEEENKLEDVVH | 951 | Q92833 | |
| IEEDHCGRLLFQPDQ | 786 | Q02241 | |
| AACEDEIPAIRNHDK | 26 | Q8IWE5 | |
| FVSALPDKLDHECAE | 1411 | P33527 | |
| EKPDCNIDAFEEDLH | 681 | Q9Y6R4 | |
| ALDSDEKCEKHFPIE | 136 | P82673 | |
| KDISLEGPHNSDNCE | 141 | Q9BQQ7 | |
| DQPRITKDVICFHAE | 611 | Q5VWQ0 | |
| QPRITKDVICFHAED | 601 | Q6PCB5 | |
| EIAENITKHLPDNEC | 136 | P54136 | |
| KPLQDTVNCEDKVHE | 921 | A2RUB1 | |
| LNPDKNCIHTDDDEK | 121 | Q9Y6N5 | |
| EEFPALHLNSCKIEE | 416 | Q9H2J7 | |
| AEEGCDLQEIHPVDL | 201 | Q14493 | |
| EVENPGHCDFVKLRT | 371 | O43236 | |
| CPHCNKEIDEIFNTE | 496 | Q4G0N8 | |
| EEHFLQEAEKEEGLP | 186 | Q5TA31 | |
| CFEIKPEENSDVHEL | 336 | Q15761 | |
| EAEVLDHSKNPCEDS | 551 | Q8WZA1 | |
| DFIHPCDQEELQDAL | 131 | Q9Y2N7 | |
| CLLDIHKIFQENDPA | 361 | Q6PI26 | |
| NDENITLETVCHDPK | 91 | P37173 | |
| KQGHECPEQALEDRV | 486 | Q8NC67 | |
| AESKLVVEPQHECLE | 3151 | Q9P2P6 | |
| EEAPGLKCQVTELHD | 401 | A8MXQ7 | |
| PNCIEHNEALLEEAK | 51 | Q13546 | |
| PNDIDVIELHDCFST | 296 | P22307 | |
| HPTLIENESICDEFA | 231 | Q14865 | |
| EFVHCAPEIEKLFQS | 2341 | A5YKK6 | |
| LKEEEIHIYQFPECD | 196 | Q8WYJ6 | |
| DDFECVTPKLEHFGI | 211 | Q8IX90 | |
| VFCDPVFQELVELKH | 801 | O95985 | |
| QVIVNDCHLPESFKE | 176 | P13682 | |
| DCHLPESFKEEENQK | 181 | P13682 | |
| QTKEGACEDPHDLLA | 96 | O94966 | |
| DCLKEFPEKQELHRN | 576 | Q7Z7L7 | |
| FHDICGPNKELDEET | 276 | P49767 | |
| LECNEHEKTFTDPLS | 256 | Q13360 | |
| VVEFAKEQDRVHSPC | 96 | Q96LT9 | |
| QNCEEKNHDLPATEV | 341 | Q96LT9 | |
| DSPDEGLDHNIHIKC | 1021 | Q13129 | |
| NEIDLFHCIDPNDSK | 51 | Q15185 | |
| HLGICKPLVEDNEEE | 766 | Q8NI35 | |
| PESAVHCSLKEEENG | 66 | Q9P227 | |
| LAEEKHTPESCFIEA | 356 | Q8N5U6 | |
| AGHKCPVDNEILLEN | 101 | Q9Y4K3 | |
| CEEGFDFPEDLQKHI | 251 | Q96K83 | |
| EAKAVPCHRQGEQEE | 126 | Q6NSZ9 | |
| ELTEFCEKHLQALAP | 56 | Q07617 | |
| SKHAVPEVIEDFLCN | 101 | Q8N0X2 | |
| FELPDNAKQCFHEEV | 31 | Q9Y3Q3 | |
| LEFHKANECQERPVE | 71 | Q6GPH4 | |
| FLCTEPHDKKEDLLE | 81 | Q9NVV9 | |
| GKIARQEELHCPSEF | 151 | Q86TI0 | |
| KHVDECLDGPSISEN | 641 | Q9UBT6 | |
| CLSEVVKEHQIPEFD | 16 | Q8IZH2 | |
| AANEPHLTLEFLEEC | 1916 | P21359 | |
| CLDFIKIQLDEPDHD | 466 | Q9GZR1 | |
| FQCQKEGPIIIHTDE | 181 | Q9NPH0 | |
| FICSEAPKEVNIDHE | 121 | O15492 | |
| TADQCPAEELKEFAH | 126 | Q9H777 | |
| TGLEQRHNKEDPDCI | 101 | Q96AE7 | |
| LNSCPEIHIDTADKE | 441 | Q92543 | |
| EQDCLPHSFHEETKE | 501 | P49190 | |
| LKHCEDPVVIDDGDS | 131 | Q96IT1 | |
| IFCEEHFPVAEQDKL | 61 | Q9NRM2 | |
| AHVICLAEEFLQEEP | 211 | Q9BQ83 | |
| KCHNPSLEVEDLSLE | 241 | Q92889 | |
| HCPIESAAEEHQEKL | 126 | A6NDI0 | |
| EKIGDVCHENSNPLE | 1156 | Q8NAP3 | |
| PKECNLIEGEDHVEV | 161 | O43314 | |
| CILATKADENHPQEE | 386 | Q9P2L0 | |
| HACDTLELKPQDREQ | 266 | Q6GMV2 | |
| ELPRVQVEHEGEFTC | 411 | Q96LC7 | |
| ENPDEACAVSQKHLI | 116 | Q5T4S7 | |
| EEELNFNEDILCPHG | 641 | Q86UV5 | |
| PGVEKFQLHDCTQVE | 301 | P08575 | |
| LENLEPEHEYKCDSE | 356 | P08575 | |
| EQLQSCKGHETEEFP | 191 | Q07283 | |
| CKGHETEEFPDEEQL | 196 | Q07283 | |
| PDRNHLACAKADLEE | 361 | Q5TAA0 | |
| TCHLKVTLAEQDPDE | 281 | P21754 | |
| IPEDCNHEEFEEIIR | 31 | A0A1B0GUJ8 | |
| LDVAHQFIKDVNPDE | 186 | A8MT70 | |
| DCQDHPRSLDELEQK | 186 | O43156 | |
| EKPKLEDEHLVFFCQ | 66 | Q8NFU3 | |
| PDIGQCHQDELERLK | 676 | Q14789 | |
| EEECKEPLLFHSGDH | 206 | Q92539 | |
| EVQDCSEPGDHKVLR | 1146 | Q8WXR4 | |
| DEILDDGQSPKHSQC | 966 | Q9ULJ8 |